During October and November, 2019, ACT developed and presented a youth and vaping webinar for health, education, mental health and addictions and community professionals. This webinar was presented three separate times and was attended by over 500 professionals from across the Province! Special thanks to Tanya Barnes-Matthews, Regional Health Educator at Western Health for taking the lead on these events. While the webinar was not recorded the slide deck with speaking notes can be found here
Recently, there has been an emergence of severe pulmonary illness related to vaping in the United States and in Canada. To date, investigations into this issue suggests that products containing THC play a role in this outbreak. The suspected cause is a chemical exposure, but the specific chemicals remain unknown at this time.
As of October 2019 information on this issue has been released by Health Canada and The CDC, and the Canadian Council of Chief Medical Officers of Health.
The Tobacco Use in Canada Report for 2019 has recently been released. This report is part of a series of reports on tobacco use in Canada. It was developed by the Propel Centre for Population Health Impact at the University of Waterloo. The report uses data from national surveys conducted by Health Canada and Statistics Canada to summarize the main patterns and trends in tobacco use in Canada, primarily since 1999, with a focus on the most current data available.
On May 1, 2019 the Honourable Ginette Petitpas Taylor, Minister of Health, announced new regulations for plain and standardized appearance of tobacco packages and products will begin to come into force on November 9, 2019.
Effective December 4, 2018, the Provincial Smoking Cessation Program will have more nicotine replacement therapy products covered under the program, specifically gum,lozenge and inhaler. This builds on the existing coverage of the patch and prescription medications Champix and Zyban.
The Provincial Smoking Cessation Program assists eligible individuals under the Newfoundland and Labrador Prescription Drug Program (NLPDP) Access, Foundation and 65 Plus Plans by contributing to the cost of quit smoking aids (prescription medications or nicotine replacement therapy). This program complements advice and assistance from health care providers and the work of the Newfoundland and Labrador Lung Association Smokers’ Helpline in helping individuals quit smoking. These efforts support the Department of Health and Community Services Chronic Disease Action Plan and the provincial governments’ Way Forward target to reduce smoking rates by 4% by 2025. For more information see